Manufacturing Industry

PFIZER INC - Research Update.

PR Newswire UK Disclose, May, 2006

 
        Pfizer's Lipitor Provides Greater Reductions in Heart Attack, 
       Stroke and Cardiovascular Procedures at an Overall Cost Savings 
                    Compared to Zocor, New Analysis Shows 
 
     * Major Study Shows That One Out of Every Six Heart Attacks, Strokes and 
       Cardiovascular Procedures Could be Avoided for Heart Disease Patients 
       Treated With Intensive Lipitor 80mg Therapy Vs. Standard Dose Zocor 
 
     * Even If the Current U.S. Price of Zocor Were Reduced by 50 Percent, 
       Lipitor Patients Could Still Achieve the Greater Cardiovascular 
       Benefits Seen in This Study at a Cost Savings for Payors 
 
     * Dr. Peter Lindgren: "This analysis suggests that the cost of using 
       Lipitor versus generic simvastatin could represent a...

            
        
    
    	    
                
                
	
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here